Results vary from person to person depending on their baseline health and consistency
Subsequent sections will provide recommendations for GLP-1based pharmacotherapy for individuals with additional CKM conditions including T2D (Section 5.5.1, Management of T2D in CKM Syndrome Stage 2 to 3), CKD (Section 5.5.4, Management of CKD in CKM Syndrome Stage 2 to 3), ASCVD (Section 6.2, Management of ASCVD ), HF (Section 6.3, Management of HF) and MASLD (Section 7.2, Metabolic DysfunctionAssociated Steatotic Liver Disease)
The cosmetic form (listed as Copper Tripeptide-1 on ingredient labels) is widely used in skincare and is regulated as a cosmetic, not a drug
Cosmetic treatments are also expected to rise as a solution for the facial results that come with rapid weight loss
10.3389/fendo.2022.1033479 Front
Despite mild discomfort, most clients feel the treatment is well worth it